219635-97-9

Upstream product

• 135056-66-5 2-phenylthiomethylacrylamide 
• 219635-80-0 (+)-N6-triphenylphosphinimino-(4'α-iodo-2'α,3'α-O-isopropylidendioxycyclopent-1'β-yl)-9-H-adenine 
• 219635-70-8 (-)-β-(2'α,3'α-dihydroxy-4'β-trimethylacetoxycyclopent-1'-yl)-9-H-adenine 
• 142695-05-4 (+)-<(1'R,4'S)-4'-hydroxy-2'-cyclopenten-1'-yl>-9-H-adenine 
• 219635-72-0 (-)-β-(2'α,3'α-O-isopropylidenedioxy-4'β-trimethylacetoxycyclopent-1'-yl)-9-H-adenine 
• 153737-56-5 (+)-<(1'R,4'S)-4'-trimethylacetoxy-2'-cyclopenten-1'-yl>-9-H-adenine 
• 153830-48-9 (-)-β-(4'β-hydroxy-2'α,3'α-O-isopropylidenedioxycyclopent-1'-yl)-9-H-adenine 
• 603-35-0 triphenylphosphine 
• 66224-66-6 adenine 
• 60410-16-4 (1R,4S)-4-hydroxy-2-cyclopentene-1-yl acetate 

Relevant academic research and scientific papers

A synthetic approach to carbocyclic sinefungin

An approach to an asymmetric synthesis of carbocyclic sinefungin (cSF) 2 is proposed. The sequence, which uses an original radical based chemistry for C-C bond formation, led to the immediate precursor 18 of the protected desired compound. While the overall yield is modest, it is noticeable that only a limited number of steps are needed to obtain the target compound.